Cancer Biology & Therapy

Taylor & Francis Group

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Cancer Biology & Therapy is an open-access journal published by Taylor & Francis Group in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,595 AUD. Declared review time at DOAJ: 11 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Taylor & Francis Group
ISSN
1538-4047 · 1555-8576
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
4,595 AUD
Articles in DOAJ
379
Declared review time
11 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2022-05-05
  • MEDLINE · 2002-01-01
  • PUBMED · 2009-03-15
Indexing
DOAJ · MEDLINE · PUBMED
APC
4,595 AUD
Declared review time (DOAJ)
11 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

379

Most recent article

last month

Average review time (journal-declared via DOAJ)

11weeks

Works in OpenAlex

5237

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

153

i10-index

3290

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-08-08
Added to DOAJ
2022-05-05
Declared plagiarism screening
Declared
Other fees beyond APC
Yes
Declared digital preservation
CLOCKSSLOCKSSPMCPorticoScholars Portal
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
94%
ORCID iDs in current deposits
92%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Cancer Biol TherCancer biology and therapy
Source type
journal
NLM unique ID (PubMed)
101137842
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • RNA modifications and cancer
  • Cell death mechanisms and regulation
  • RNA modifications and cancer
  • Cell death mechanisms and regulation
Show all subjects (50)
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Ubiquitin and proteasome pathways
  • Ubiquitin and proteasome pathways
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • PI3K/AKT/mTOR signaling in cancer
  • PI3K/AKT/mTOR signaling in cancer
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Circular RNAs in diseases
  • Circular RNAs in diseases
  • Angiogenesis and VEGF in Cancer
  • Angiogenesis and VEGF in Cancer
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers

Keywords (DOAJ)

  • oncology
  • cancer biology
  • cancer therapy
  • chemotherapy
  • molecular oncology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: